Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure
Conclusion There is no difference in mortality among hepatic and extrahepatic ACLF groups at 28 and 90 days. iMELD and CLIF-SOFA have highest AUROC to predict 28-day mortality in hepatic and extrahepatic ACLF groups, respectively.
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research
More News: Alcoholism | Autoimmune Disease | Cirrhosis | Gastroenterology | Hepatitis | Hepatitis A | Hepatitis B | Liver | Liver Disease | Physiology | Study | Urology & Nephrology